MHRA Review of UK Trial Applications Reveals New B...
Category : ODD/BTA/FTA Status 14 April 2025The first-ever analysis of the UK clinical trial landscape by the Medicines and Healthcare products...
The first-ever analysis of the UK clinical trial landscape by the Medicines and Healthcare products...
Avidity Biosciences, Inc, a biopharmaceutical company committed to delivering a new class of RNA the...
The US Food and Drug Administration (FDA) has granted orphan drug designation to rilzabrutinib, an i...
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufact...
The US Food and Drug Administration (FDA) has granted fast track designation to Sanofi’s mRNA...